Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Moretta

Showing results (181-190 of 205) with videos related to

Pageof 21
Sort By:
Clinical & Translational Immunology|August 10, 2017
NKG2C<sup>+</sup> memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147Françoise Gondois-Rey, Antoine Chéret, Samuel Granjeaud, et al.
European Journal of Immunology|March 19, 2016
Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1Claudia Alicata, Daniela Pende, Raffaella Meazza, et al.
Cancer Research|May 20, 2016
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor ActivityChristine Pasero, Gwenaëlle Gravis, Mathilde Guerin, et al.
Blood|January 24, 2015
γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytesIrma Airoldi, Alice Bertaina, Ignazia Prigione, et al.
The Journal of Experimental Medicine|June 17, 2009
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humansCameron S Brandt, Myriam Baratin, Eugene C Yi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activationChiara Romagnani, Kerstin Juelke, Michela Falco, et al.
European Journal of Immunology|March 30, 2004
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptorsPascale André, Roberta Castriconi, Marion Espéli, et al.
The Journal of Allergy and Clinical Immunology|January 25, 2021
HCMV-controlling NKG2C<sup>+</sup> NK cells originate from novel circulating inflammatory precursorsFederica Bozzano, Mariella Della Chiesa, Andrea Pelosi, et al.
Blood|June 26, 2009
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cellsFrancois Romagné, Pascale André, Pieter Spee, et al.
Nature Communications|December 5, 2014
Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patientsTalib Hassan Ali, Simona Pisanti, Elena Ciaglia, et al.
Pageof 21

Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
Clinical & Translational Immunology|August 10, 2017
NKG2C<sup>+</sup> memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147Françoise Gondois-Rey, Antoine Chéret, Samuel Granjeaud, et al.
European Journal of Immunology|March 19, 2016
Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1Claudia Alicata, Daniela Pende, Raffaella Meazza, et al.
Cancer Research|May 20, 2016
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor ActivityChristine Pasero, Gwenaëlle Gravis, Mathilde Guerin, et al.
Blood|January 24, 2015
γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytesIrma Airoldi, Alice Bertaina, Ignazia Prigione, et al.
The Journal of Experimental Medicine|June 17, 2009
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humansCameron S Brandt, Myriam Baratin, Eugene C Yi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activationChiara Romagnani, Kerstin Juelke, Michela Falco, et al.
European Journal of Immunology|March 30, 2004
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptorsPascale André, Roberta Castriconi, Marion Espéli, et al.
The Journal of Allergy and Clinical Immunology|January 25, 2021
HCMV-controlling NKG2C<sup>+</sup> NK cells originate from novel circulating inflammatory precursorsFederica Bozzano, Mariella Della Chiesa, Andrea Pelosi, et al.
Blood|June 26, 2009
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cellsFrancois Romagné, Pascale André, Pieter Spee, et al.
Nature Communications|December 5, 2014
Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patientsTalib Hassan Ali, Simona Pisanti, Elena Ciaglia, et al.
Pageof 21